These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 38539529)

  • 1. CD44 in Bladder Cancer.
    Duex J; Theodorescu D
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells.
    Senbanjo LT; Chellaiah MA
    Front Cell Dev Biol; 2017; 5():18. PubMed ID: 28326306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 as a tumor biomarker and therapeutic target.
    Xu H; Niu M; Yuan X; Wu K; Liu A
    Exp Hematol Oncol; 2020 Dec; 9(1):36. PubMed ID: 33303029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.
    Azevedo R; Gaiteiro C; Peixoto A; Relvas-Santos M; Lima L; Santos LL; Ferreira JA
    Clin Proteomics; 2018; 15():22. PubMed ID: 29983670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of CD44 in Disease Pathophysiology and Targeted Treatment.
    Jordan AR; Racine RR; Hennig MJ; Lokeshwar VB
    Front Immunol; 2015; 6():182. PubMed ID: 25954275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 Glycosylation as a Therapeutic Target in Oncology.
    Liao C; Wang Q; An J; Chen J; Li X; Long Q; Xiao L; Guan X; Liu J
    Front Oncol; 2022; 12():883831. PubMed ID: 35936713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular studies into the role of CD44 variants in metastasis in gastric cancer.
    Hsieh HF; Yu JC; Ho LI; Chiu SC; Harn HJ
    Mol Pathol; 1999 Feb; 52(1):25-8. PubMed ID: 10439835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
    Anand V; Khandelwal M; Appunni S; Gupta N; Seth A; Singh P; Mathur S; Sharma A
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2649-2661. PubMed ID: 31529191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine.
    Mattheolabakis G; Milane L; Singh A; Amiji MM
    J Drug Target; 2015; 23(7-8):605-18. PubMed ID: 26453158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
    Gaiteiro C; Soares J; Relvas-Santos M; Peixoto A; Ferreira D; Paulo P; Brandão A; Fernandes E; Azevedo R; Palmeira C; Freitas R; Miranda A; Osório H; Prieto J; Lima L; Silva AMN; Santos LL; Ferreira JA
    Theranostics; 2022; 12(7):3150-3177. PubMed ID: 35547758
    [No Abstract]   [Full Text] [Related]  

  • 14. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.
    Lin NY; Lee JJ; Chen ST; Lin JA; Lin CH; Lin HY; Su YH; Chen CC; Lin MC; Kuo CY; Huang MC
    Mol Cancer Res; 2023 Jul; 21(7):664-674. PubMed ID: 37040171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
    Dasgupta A; Takahashi K; Cutler M; Tanabe KK
    Biochem Biophys Res Commun; 1996 Oct; 227(1):110-7. PubMed ID: 8858111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
    Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S
    BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD44 in breast cancer.
    Al-Othman N; Alhendi A; Ihbaisha M; Barahmeh M; Alqaraleh M; Al-Momany BZ
    Breast Dis; 2020; 39(1):1-13. PubMed ID: 31839599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
    Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Role of CD44 Receptor as a Potential Target in Disease Diagnosis: A Patent Review.
    Pandey S; Mahtab A; Rai N; Rawat P; Ahmad FJ; Talegaonkar S
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):77-91. PubMed ID: 28891438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.